Diagnostic accuracy of polymerase chain reaction for detection of mpox in humans

Exactitud diagnóstica de la reacción en cadena de la polimerasa para la detección de la mpox en el ser humano

Acurácia diagnóstica da reação em cadeia da polimerase para detecção da varíola símia em humanos

Greeshma Unnikrishnan Abhinav Singh Abhishek Purohit About the authors

ABSTRACT

Objective.

To evaluate diagnostic accuracy of polymerase chain reaction (PCR) in detecting mpox infection in humans by pooling the estimates of sensitivity and specificity across different study settings.

Methods.

A systematic search was conducted in PubMed, Cochrane database, Scopus, and Google Scholar. Studies that evaluated the diagnostic accuracy of PCR test for the detection of monkeypox virus providing the sensitivity and specificity values and the total number of samples were included. The sensitivity and specificity values of PCR test were pooled for all the included studies. The meta-analysis was conducted in accordance with PRISMA guidelines using the metadta package in STATA software. A summary receiver operating characteristic (SROC) curve and forest plot were generated. The protocol was registered in PROSPERO (CRD-NIHR) database with Reference ID CRD42024590183.

Results.

Twelve studies were included for meta-analysis. The pooled sensitivity and specificity estimate across all the studies using a random effects model was 0.99 (95% CI [0.95, 1.00]) and 1 (95% CI [0.96, 1.00]), respectively. The SROC curve confirmed high diagnostic accuracy of PCR. The quality assessment of diagnostic accuracy studies (QUADAS) tool depicted low risk of bias.

Conclusions.

This systematic review and meta-analysis is the first study in the scientific literature to provide a pooling for diagnostic accuracy for PCR test for mpox and confirms it as an accurate tool in detecting the infection in humans.

Keywords
Mpox (monkeypox); monkeypox virus; polymerase chain reaction; diagnosis; meta-analysis

RESUMEN

Objetivo.

Evaluar la exactitud diagnóstica de la reacción en cadena de la polimerasa (PCR) en la detección de la infección de mpox en el ser humano agrupando las estimaciones de sensibilidad y especificidad obtenidas en diferentes entornos de estudio.

Métodos.

Se realizó una búsqueda sistemática en PubMed, la base de datos Cochrane, Scopus y Google Scholar. Se incluyeron los estudios que evaluaron la exactitud diagnóstica de la prueba de PCR para la detección del virus de la mpox y proporcionaron los valores de sensibilidad y especificidad, así como el número total de muestras. Se agruparon los valores de sensibilidad y especificidad de la prueba de PCR de todos los estudios incluidos. El metanálisis se llevó a cabo siguiendo lo establecido en las directrices PRISMA, con el empleo del conjunto de metadatos, mediante el programa STATA. Se generó una curva de características operativas del receptor resumida (SROC) y un diagrama de bosque. El protocolo se registró en la base de datos PROSPERO (CRD-NIHR) con la identificación de referencia CRD42024590183.

Resultados.

Se incluyeron doce estudios en el metanálisis. La estimación agrupada de la sensibilidad y la especificidad en el conjunto de los estudios, con un modelo de efectos aleatorios, fue de 0,99 (IC del 95%: [0,95; 1,00]) y 1 (IC del 95%: [0,96; 1,00]), respectivamente. La curva SROC confirmó la gran exactitud diagnóstica de la PCR. La herramienta de evaluación de la calidad de los estudios de exactitud diagnóstica (QUADAS) mostró un riesgo bajo de sesgo.

Conclusiones.

Esta revisión sistemática y metanálisis es el primer estudio científico publicado que utiliza una agrupación de estudios para determinar la exactitud diagnóstica de la PCR en la mpox, y confirma que se trata de un análisis exacto para la detección de la infección en el ser humano.

Palabras clave
Mpox; monkeypox virus; reacción en cadena de la polimerasa; diagnóstico; metaanálisis

RESUMO

Objetivo.

Avaliar a acurácia diagnóstica da reação em cadeia da polimerase (PCR) para detectar a infecção pelo vírus da varíola símia (mpox) em humanos, combinando as estimativas de sensibilidade e de especificidade de estudos em diferentes contextos.

Métodos.

Foi realizada uma pesquisa sistemática das bases de dados PubMed, Cochrane, Scopus e Google Acadêmico. Foram incluídos na análise estudos que avaliaram a acurácia diagnóstica do teste de PCR para a detecção do vírus da varíola símia e que apresentavam os resultados de sensibilidade e especificidade e o número total de amostras. Os dados de sensibilidade e especificidade de todos os estudos incluídos na revisão foram combinados. A metanálise foi conduzida conforme as diretrizes PRISMA com o uso do pacote de metadados do software STATA. Os dados foram representados em uma curva característica de operação do receptor sumarizada (sROC) e um gráfico de floresta. O protocolo da revisão foi registrado na base PROSPERO (CRD-NIHR), sob o número de referência CRD42024590183.

Resultados.

Doze estudos foram incluídos na metanálise. As estimativas combinadas de sensibilidade e especificidade dos estudos com o uso de um modelo de efeitos aleatórios foram 0,99 (IC 95% [0,95, 1,00]) e 1 (IC 95% [0,96, 1,00]), respectivamente. A curva sROC confirmou a elevada acurácia diagnóstica do teste de PCR. A ferramenta de avaliação da qualidade dos estudos de acurácia diagnóstica (QUADAS) indicou baixo risco de viés.

Conclusões.

Esta revisão sistemática e metanálise é o primeiro estudo da literatura científica a combinar os resultados de acurácia diagnóstica do teste de PCR para varíola símia, confirmando que este é um instrumento preciso para detectar essa infecção em humanos.

Palavras-chave
Mpox; monkeypox virus; reação em cadeia da polimerase; diagnóstico; metanálise

The World Health Organization (WHO) declared mpox, previously known as monkeypox, as a public health emergency of international concern (PHEIC) in 2024 with the recent upsurge of mpox infections causing more than 15 600 cases and 537 deaths so far this year, and following the emergence of a new monkeypox virus strain, clade 1b, in the Democratic Republic of the Congo (11. World Health Organization. WHO Director-General declares mpox outbreak a public health emergency of international concern. 14 August 2024. Geneva: WHO; 2024 [cited 17 September 2024]. Available from: https://www.who.int/news/item/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern.
https://www.who.int/news/item/14-08-2024...
). An earlier multi-country outbreak in 2022 was also declared as a PHEIC, when mpox was transmitted rapidly via sexual contact in endemic and nonendemic countries and warranted a worldwide public health response to contain the infection (22. Jeyaraman M, Selvaraj P, Halesh MB, Jeyaraman N, Nallakumarasamy A, Gupta M, et al. Monkeypox: An Emerging Global Public Health Emergency. Life (Basel). 2022;12(10):1590. https://doi.org/10.3390/life12101590.
https://doi.org/10.3390/life12101590...
).

Monkeypox virus is a zoonotic double stranded DNA virus that belongs to the Orthopoxvirus genus of the Poxviridae family and is closely related to the smallpox/variola and cowpox viruses. Monkeypox virus was first identified in a laboratory monkey in 1958, but rodents are also potential hosts. Mpox is endemic in western and central Africa, where the monkeypox virus is present in wildlife but can also sporadically be transmitted to humans (33. Peris MP, Clusa L, Alonso H, Escolar C, Fortuño B, Rezusta A, et al. Clinical Performance Evaluation of a Rapid Real-Time PCR Assay for Monkeypox Diagnosis: a Retrospective and Comparative Study. Microbiol Spectr. 2023;11(3):e0051023. https://doi.org/10.1128/spectrum.00510-23.
https://doi.org/10.1128/spectrum.00510-2...
). The monkeypox virus has two phylogenetically distinct clades: clades I and II. Clade I (with subclades Ia and Ib) predominantly circulates in the Congo Basin and is believed to cause more severe disease in humans than clade II (with subclades IIa and IIb), which is more commonly seen in West Africa (44. Americo JL, Earl PL, Moss B. Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. Proc Natl Acad Sci USA. 2023;120(8):e2220415120. https://doi.org/10.1073/pnas.2220415120.
https://doi.org/10.1073/pnas.2220415120...
).

Exposure to the virus through physical contact with animals can occur through bites, scratches, or during activities like hunting, skinning, meal preparation, and consuming uncooked meat. Between humans, the spread can occur through bodily fluids, skin or internal mucosal surface lesions, respiratory droplets from infected animals or humans, and fomites (55. Chaix E, Boni M, Guillier L, Bertagnoli S, Mailles A, Collignon C, et al. Risk of Monkeypox virus (MPXV) transmission through the handling and consumption of food. Microb Risk Anal. 2022;22:100237. https://doi.org/10.1016/j.mran.2022.100237.
https://doi.org/10.1016/j.mran.2022.1002...
). The virus can also be transmitted vertically through placenta to the fetus or to the newborn after birth (66. World Health Organization. Mpox. Geneva: WHO; 2024 [cited 17 September 2024]. Available from: https://www.who.int/health-topics/mpox.
https://www.who.int/health-topics/mpox...
). In 2022, the incidence of the mpox was more frequent among homosexual and bisexual men (77. Philpott D, Hughes CM, Alroy KA, Kerins JL, Pavlick J, Asbel L, et al. Epidemiologic and clinical characteristics of monkeypox cases – United States, May 17–July 22, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(32):1018–1022. https://doi.org/10.15585/mmwr.mm7132e3.
https://doi.org/10.15585/mmwr.mm7132e3...
).

The typical presentation of mpox is well established, starting with a febrile prodromal phase followed by development of a characteristic rash, typically beginning on the face and spreading to the limbs and trunk. Lesions transition from macules to papules, vesicles, pustules, and finally crusts, which eventually fall off over 2–4 weeks. Other systemic symptoms such as myalgia, lymphadenopathy, and asthenia are also frequently seen (88. World Health Organization. Laboratory testing for the monkeypox virus: interim guidance, 23 May 2022. Geneva: WHO; 2022. Available from: https://iris.who.int/handle/10665/354488.
https://iris.who.int/handle/10665/354488...
). Some mpox cases (40% in one study) reported travel history from regions where the virus is endemic (88. World Health Organization. Laboratory testing for the monkeypox virus: interim guidance, 23 May 2022. Geneva: WHO; 2022. Available from: https://iris.who.int/handle/10665/354488.
https://iris.who.int/handle/10665/354488...
, 99. Harshani HBC, Liyanage GA, Ruwan DVRG, Samaraweera UKIU, Abeynayake JI. Evaluation of the diagnostic performance of a commercial molecular assay for the screening of suspected monkeypox cases in Sri Lanka. Infect Med (Beijing). 2023;2(2):136–142. https://doi.org/10.1016/j.imj.2023.05.002.
https://doi.org/10.1016/j.imj.2023.05.00...
).

Viral culture, electron microscopy, serological tests, and polymerase chain reaction (PCR) test are the various methods available for diagnosis of mpox infections (1010. McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014;58(2):260–267. https://doi.org/10.1093/cid/cit703.
https://doi.org/10.1093/cid/cit703...
). Viral culture should only be conducted in specified biosafety level 2 laboratories with appropriate experience and is not commonly used for diagnosis of the infection. The use of electron microscopy for routine diagnosis is also limited given the need for sophisticated laboratories and equipment. Serological tests are mostly used to detect the antibodies against the orthopoxviruses, but these tests cannot be solely relied upon as they do not detect the virus itself but only indicate exposure to the virus. Therefore, the gold standard for diagnosing mpox infection in humans, as declared by WHO, is real-time PCR, which should be the first test conducted on a suspected case (1111. Cheema AY, Ogedegbe OJ, Munir M, Alugba G, Ojo TK. Monkeypox: A Review of Clinical Features, Diagnosis, and Treatment. Cureus. 2022;14(7):e26756. https://doi.org/10.7759/cureus.26756.
https://doi.org/10.7759/cureus.26756...
). PCR is a nucleic acid amplification test (NAAT) through which unique sequences of viral DNA can be detected. It is a highly sensitive and specific test that can detect even small amounts of viral DNA, which is crucial for early diagnosis of the disease and therefore to reduce transmission of the infection (1212. Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis. 2004;4(6):337–348. https://doi.org/10.1016/s1473-3099(04)01044-8.
https://doi.org/10.1016/s1473-3099(04)01...
).

The sensitivity of a diagnostic test is a measure of its ability to identify true positives (those with the disease are rightly identified as positive); whereas the specificity of a test is a measure of its ability to identify true negatives (those without the disease are rightly identified as negative). Several studies have reported the sensitivity and specificity of PCR in diagnosing mpox (33. Peris MP, Clusa L, Alonso H, Escolar C, Fortuño B, Rezusta A, et al. Clinical Performance Evaluation of a Rapid Real-Time PCR Assay for Monkeypox Diagnosis: a Retrospective and Comparative Study. Microbiol Spectr. 2023;11(3):e0051023. https://doi.org/10.1128/spectrum.00510-23.
https://doi.org/10.1128/spectrum.00510-2...
, 99. Harshani HBC, Liyanage GA, Ruwan DVRG, Samaraweera UKIU, Abeynayake JI. Evaluation of the diagnostic performance of a commercial molecular assay for the screening of suspected monkeypox cases in Sri Lanka. Infect Med (Beijing). 2023;2(2):136–142. https://doi.org/10.1016/j.imj.2023.05.002.
https://doi.org/10.1016/j.imj.2023.05.00...
, 1313. Sklenovská N, Bloemen M, Vergote V, Logist AS, Vanmechelen B, Laenen L, et al. Design and validation of a laboratory-developed diagnostic assay for monkeypox virus. Virus Genes. 2023;59(6):795–800. https://doi.org/10.1007/s11262-023-02024-9.
https://doi.org/10.1007/s11262-023-02024...
2222. Wettengel JM, Bunse T, Jeske SD, Wölfel R, Zange S, Taeubner J, et al. Implementation and clinical evaluation of an Mpox virus laboratory-developed test on a fully automated random-access platform. J Med Virol. 2023;95(8):e29022. https://doi.org/10.1002/jmv.29022.
https://doi.org/10.1002/jmv.29022...
). However, there is no pooled evidence of the diagnostic accuracy of the sensitivity and specificity of the PCR test confirming the routine diagnosis of mpox infection. Therefore, this study aims to pool the estimates of sensitivity and specificity across different study settings and provide evidence on the diagnostic accuracy of PCR in detecting mpox infections in humans.

MATERIALS AND METHODS

Protocol and registration

This meta-analysis was conducted in accordance with PRISMA guidelines. The protocol was registered in the PROSPERO (CRD-NIHR) database with Reference ID CRD42024590183.

Eligibility criteria

Studies that met all the following criteria were included for the analysis: 1) evaluated the diagnostic performance of PCR for the detection of mpox in humans; 2) provided the sensitivity and specificity values of the PCR test used; and 3) provided the total number of samples included in the study.

Reference/index test

Reference/index test was PCR, whose sensitivity and specificity values were pooled for all the included studies to assess its diagnostic accuracy in the detection of mpox infection in human samples.

Search strategy

A systematic search of scientific literature was conducted following PRISMA guidelines to identify studies evaluating the diagnostic accuracy of PCR for detection of mpox infections in humans. The search was conducted in the electronic databases PubMed, Cochrane, Scopus, and Google Scholar. Search terms included were “diagnostic accuracy,” “evaluation,” “validation,” “polymerase chain reaction,” “PCR,” “PCR assay,” “monkeypox,” and “mpox.” These terms were combined using Boolean operators AND or OR to obtain the final search string. The search was not restricted by any date or language. Gray literature was searched through unpublished articles and manual searching of nonindexed journals at the institutional library at All India Institute of Medical Sciences (AIIMS), Bhopal, including abstracts, conference presentations, online clinical registries, but no articles were retrieved based on these criteria.

Study selection and data extraction

Two independent reviewers (GU and AS) screened the titles and abstracts of the articles for eligibility followed by a full text review of the selected articles. The reasons for the exclusion of articles were noted. Additionally, references of the selected articles were hand searched and retrieved if deemed potentially relevant. Discrepancies between the reviewers were resolved through discussion and consensus. If consensus could not be reached, a third reviewer with relevant subject expertise was available to resolve. The following details of the included studies were extracted into a pilot worksheet by the two reviewers (GU and AS): 1) author name; 2) year of publication; 3) country; 4) sample size; 5) sensitivity and specificity values of the diagnostic test (PCR). The information was rechecked for accuracy by a third reviewer.

Quality assessment

The risk of bias of the included studies was assessed using the quality assessment of diagnostic accuracy studies-2 tool (QUADAS-2) (2323. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536. https://doi.org/10.7326/0003-4819-155-8-201110180-00009.
https://doi.org/10.7326/0003-4819-155-8-...
). The tool assesses the risk of bias for the included studies under four domains: 1) patient selection; 2) index test; 3) reference standard; 4) flow and timing. The two reviewers (GU and AS) adapted the signaling questions and assessment criteria to create a review-specific version of the tool. Once the agreement was reached it was used by the authors to assess independently the risk of bias and its applicability to all the included studies. The index test itself is the reference standard in the present study, whose diagnostic accuracy is being assessed. The term sample was used in place of patient, since only the samples were received from various laboratories and tertiary care centers for analysis.

Statistical analysis

The meta-analysis was conducted using the metadta package in STATA software (version 17; StataCorp LLC, College Station, TX, USA), which is specifically designed for meta-analysis of diagnostic test accuracy studies (2424. Nyaga VN. METADTA: Stata module to perform fixed- and random-effects meta-analysis and meta-regression of diagnostic accuracy studies. Statistical Software Components S458794. Boston College Department of Economics; 2020. Revised 11 November 2022. Available from: https://ideas.repec.org/c/boc/bocode/s458794.html.
https://ideas.repec.org/c/boc/bocode/s45...
, 2525. Nyaga VN, Arbyn M. Metadta: a Stata command for meta-analysis and meta-regression of diagnostic test accuracy data - a tutorial. Arch Public Health. 2022;80(1):95. https://doi.org/10.1186/s13690-021-00747-5.
https://doi.org/10.1186/s13690-021-00747...
). The sensitivity and specificity data were analyzed using bivariate and hierarchical models. Summary receiver operating characteristic (SROC) curve and forest plot were generated, which are essential for assessing heterogeneity and overall test performance across studies. We used the restricted maximum likelihood (REML) method for parameter estimation.

RESULTS

The search yielded 11 398 articles from the various electronic databases. After title and abstract screening by the two reviewers, 57 articles that met inclusion criteria were included for full text review. A total of 12 articles were included for the final analysis after removal of duplicates and excluding the articles that did not meet the inclusion criteria (Table 1 and 2). A PRISMA flow diagram of the study selection process is provided in Figure 1.

TABLE 1.
Characteristics of studies included in the meta-analysis
TABLE 2.
Characteristics of studies excluded from the meta-analysis
FIGURE 1.
Flow diagram of the study selection process

Eleven of the 12 included studies reported high sensitivity values with point estimates ranging from 0.93 to 1. One study reported a lower sensitivity value of 0.60 (1919. Pomari E, Mori A, Accordini S, Donini A, Cordioli M, Tacconelli E, et al. Evaluation of a ddPCR commercial assay for the absolute quantification of the Monkeypox virus West Africa in clinical samples. Diagnostics (Basel). 2023;13(7):1349. https://doi.org/10.3390/diagnostics13071349.
https://doi.org/10.3390/diagnostics13071...
). The random effects model used for the meta-analysis reported a pooled estimate of 0.99 (95% CI [0.95, 1.00]) (Figure 2), which suggested that PCR demonstrated excellent diagnostic accuracy in the detection of mpox infections in humans, with a sensitivity approaching 99%.

FIGURE 2.
Pooled estimate of sensitivity and specificity of PCR test

The point estimates across different studies ranged from 0.82 to 1 with respect to the specificity of the PCR test. The estimates of three studies (99. Harshani HBC, Liyanage GA, Ruwan DVRG, Samaraweera UKIU, Abeynayake JI. Evaluation of the diagnostic performance of a commercial molecular assay for the screening of suspected monkeypox cases in Sri Lanka. Infect Med (Beijing). 2023;2(2):136–142. https://doi.org/10.1016/j.imj.2023.05.002.
https://doi.org/10.1016/j.imj.2023.05.00...
, 1818. Tan NK, Madona CP, Taylor JF, Fourali LH, Sehmi JK, Stone MJ, et al. Performance evaluation of the Viasure PCR assay for the diagnosis of monkeypox: A multicentre study. J Clin Virol. 2023;158:105350. https://doi.org/10.1016/j.jcv.2022.105350.
https://doi.org/10.1016/j.jcv.2022.10535...
, 1919. Pomari E, Mori A, Accordini S, Donini A, Cordioli M, Tacconelli E, et al. Evaluation of a ddPCR commercial assay for the absolute quantification of the Monkeypox virus West Africa in clinical samples. Diagnostics (Basel). 2023;13(7):1349. https://doi.org/10.3390/diagnostics13071349.
https://doi.org/10.3390/diagnostics13071...
) revealed wider confidence intervals in comparison to other studies, indicating less precision in the specificity of the PCR test probably due to variations in PCR methodology or sample quality. The pooled estimate of specificity was 1 (95% CI [0.96, 1.00]) (Figure 2), which reflects excellent specificity of PCR test in identifying the true negatives. If a study provided multiple sensitivity and specificity values, the lower estimate was chosen to be included in the analysis to reflect the minimum possible values.

A summary receiver operating characteristic (SROC) curve was plotted to further confirm the overall diagnostic accuracy of the PCR test (Figure 3). A SROC curve consists of the following components: 1) the summary point; 2) prediction region; and 3) confidence region. The summary point provides an overall summary of the diagnostic accuracy of a test considering both sensitivity and specificity. The dotted line around the summary point represents the prediction region, which suggests the range of likely values of sensitivity and specificity for future studies. A narrow prediction region suggests consistent performance of a diagnostic test. The dashed line around the summary point is the confidence region, which represents the uncertainty in the pooled estimates of sensitivity and specificity values. A smaller confidence region reflects lesser variability or more precision of the estimates. The positioning of the summary point of the SROC curve near the top left corner, and the narrow prediction region and confidence region, reflects the high sensitivity and specificity values, which further reiterates the robust and consistent performance of PCR in diagnosing mpox infections in different study settings.

FIGURE 3.
Summary receiver operating characteristic (SROC) curve

The quality of the included studies was assessed utilizing the QUADAS-2 tool. The signaling questions of the tool were adapted to the needs of the review, as the index test was the reference standard. A low risk of bias was observed for estimating the diagnostic accuracy of the index/reference test (Table 3).

TABLE 3.
Summary of QUADAS-2 quality appraisal of included studies

DISCUSSION

This systematic review and meta-analysis evaluated the diagnostic accuracy of PCR test in detecting mpox infections in humans. The pooled estimate of sensitivity and specificity of PCR test demonstrated excellent diagnostic performance of the test with a pooled sensitivity of 0.99 (95% CI [0.95, 1.00]) and a specificity of 1 (95% CI [0.96, 1.00]). A SROC curve with summary point positioned in the top left corner, along with narrow confidence and prediction regions, confirms the diagnostic accuracy of PCR in the detection of mpox infection in humans across diverse study settings.

The ability of PCR to detect low viral loads early in the infection is indispensable for early-stage diagnosis to provide timely treatment and prevent further transmission of the infection. During an outbreak, early and specific identification is of paramount importance to public health. In populations at high risk for coinfection or presenting undifferentiated rashes, an assay of high specificity is crucial. Among the included studies, the most common coinfections reported were HIV, Chlamydia trachomatis, Neisseria gonorrhoeae, herpes simplex virus 1 and 2, varicella zoster virus, and Treponema pallidum (33. Peris MP, Clusa L, Alonso H, Escolar C, Fortuño B, Rezusta A, et al. Clinical Performance Evaluation of a Rapid Real-Time PCR Assay for Monkeypox Diagnosis: a Retrospective and Comparative Study. Microbiol Spectr. 2023;11(3):e0051023. https://doi.org/10.1128/spectrum.00510-23.
https://doi.org/10.1128/spectrum.00510-2...
, 1515. Pond MJ, Al-Mufti J, Madona P, Crone MA, Laing KG, Hale RS, et al. Mpox infection investigation using multiplexed syndromic diagnostics: Evaluation of an AusDiagnostics multiplexed tandem PCR (MT-PCR) syndromic panel. J Clin Virol Plus. 2023;3(2):100142. https://doi.org/10.1016/j.jcvp.2023.100142.
https://doi.org/10.1016/j.jcvp.2023.1001...
, 2121. De Pace V, Bruzzone B, Ricucci V, Domnich A, Guarona G, Garzillo G, et al. Molecular Diagnosis of Human Monkeypox Virus during 2022–23 Outbreak: Preliminary Evaluation of Novel Real-Time Qualitative PCR Assays. Microorganisms. 2024;12(4):664. https://doi.org/10.3390/microorganisms12040664.
https://doi.org/10.3390/microorganisms12...
).

In the included studies, samples analyzed were mainly obtained from skin lesions (1313. Sklenovská N, Bloemen M, Vergote V, Logist AS, Vanmechelen B, Laenen L, et al. Design and validation of a laboratory-developed diagnostic assay for monkeypox virus. Virus Genes. 2023;59(6):795–800. https://doi.org/10.1007/s11262-023-02024-9.
https://doi.org/10.1007/s11262-023-02024...
, 1919. Pomari E, Mori A, Accordini S, Donini A, Cordioli M, Tacconelli E, et al. Evaluation of a ddPCR commercial assay for the absolute quantification of the Monkeypox virus West Africa in clinical samples. Diagnostics (Basel). 2023;13(7):1349. https://doi.org/10.3390/diagnostics13071349.
https://doi.org/10.3390/diagnostics13071...
, 2020. Elbaz M, Halutz O, Ali Y, Adler A. Diagnosis of Monkeypox infection: Validation of two diagnostic kits for viral detection using RT-PCR. J Virol Methods. 2023;312:114653. https://doi.org/10.1016/j.jviromet.2022.114653.
https://doi.org/10.1016/j.jviromet.2022....
), oropharynx (1818. Tan NK, Madona CP, Taylor JF, Fourali LH, Sehmi JK, Stone MJ, et al. Performance evaluation of the Viasure PCR assay for the diagnosis of monkeypox: A multicentre study. J Clin Virol. 2023;158:105350. https://doi.org/10.1016/j.jcv.2022.105350.
https://doi.org/10.1016/j.jcv.2022.10535...
, 1919. Pomari E, Mori A, Accordini S, Donini A, Cordioli M, Tacconelli E, et al. Evaluation of a ddPCR commercial assay for the absolute quantification of the Monkeypox virus West Africa in clinical samples. Diagnostics (Basel). 2023;13(7):1349. https://doi.org/10.3390/diagnostics13071349.
https://doi.org/10.3390/diagnostics13071...
, 2020. Elbaz M, Halutz O, Ali Y, Adler A. Diagnosis of Monkeypox infection: Validation of two diagnostic kits for viral detection using RT-PCR. J Virol Methods. 2023;312:114653. https://doi.org/10.1016/j.jviromet.2022.114653.
https://doi.org/10.1016/j.jviromet.2022....
), and rectum (33. Peris MP, Clusa L, Alonso H, Escolar C, Fortuño B, Rezusta A, et al. Clinical Performance Evaluation of a Rapid Real-Time PCR Assay for Monkeypox Diagnosis: a Retrospective and Comparative Study. Microbiol Spectr. 2023;11(3):e0051023. https://doi.org/10.1128/spectrum.00510-23.
https://doi.org/10.1128/spectrum.00510-2...
, 1919. Pomari E, Mori A, Accordini S, Donini A, Cordioli M, Tacconelli E, et al. Evaluation of a ddPCR commercial assay for the absolute quantification of the Monkeypox virus West Africa in clinical samples. Diagnostics (Basel). 2023;13(7):1349. https://doi.org/10.3390/diagnostics13071349.
https://doi.org/10.3390/diagnostics13071...
, 2020. Elbaz M, Halutz O, Ali Y, Adler A. Diagnosis of Monkeypox infection: Validation of two diagnostic kits for viral detection using RT-PCR. J Virol Methods. 2023;312:114653. https://doi.org/10.1016/j.jviromet.2022.114653.
https://doi.org/10.1016/j.jviromet.2022....
). Pomari et al. (1919. Pomari E, Mori A, Accordini S, Donini A, Cordioli M, Tacconelli E, et al. Evaluation of a ddPCR commercial assay for the absolute quantification of the Monkeypox virus West Africa in clinical samples. Diagnostics (Basel). 2023;13(7):1349. https://doi.org/10.3390/diagnostics13071349.
https://doi.org/10.3390/diagnostics13071...
) collected samples from whole blood along with samples from other sites, and Peris et al. (33. Peris MP, Clusa L, Alonso H, Escolar C, Fortuño B, Rezusta A, et al. Clinical Performance Evaluation of a Rapid Real-Time PCR Assay for Monkeypox Diagnosis: a Retrospective and Comparative Study. Microbiol Spectr. 2023;11(3):e0051023. https://doi.org/10.1128/spectrum.00510-23.
https://doi.org/10.1128/spectrum.00510-2...
) collected swabs from the genital area as well. According to WHO standards, the specimens from skin lesion surface or lesion crusts from various sites including genital, oropharyngeal, and perianal areas are the most preferred specimens for detection of mpox infection by PCR (88. World Health Organization. Laboratory testing for the monkeypox virus: interim guidance, 23 May 2022. Geneva: WHO; 2022. Available from: https://iris.who.int/handle/10665/354488.
https://iris.who.int/handle/10665/354488...
). Blood samples are not preferred, as the shedding of virus in the blood happens during the prodromal period typically before the appearance of the skin lesions. Additionally, antigen and antibody assays are often unsuitable, as monkeypox virus exhibits cross-reactivity with other orthopoxviruses (2020. Elbaz M, Halutz O, Ali Y, Adler A. Diagnosis of Monkeypox infection: Validation of two diagnostic kits for viral detection using RT-PCR. J Virol Methods. 2023;312:114653. https://doi.org/10.1016/j.jviromet.2022.114653.
https://doi.org/10.1016/j.jviromet.2022....
).

Although WHO has declared PCR as the gold standard for the detection of mpox infection based on expert consensus, to our knowledge, no single study has comprehensively evaluated the overall diagnostic accuracy of PCR in the detection of mpox across varied study settings. This review provides the pooled estimates of sensitivity and specificity of the test across different studies conducted from different samples and confirms the diagnostic accuracy of the test. This study also serves as a foundation for future diagnostic research and sets a stage for monitoring the accuracy of PCR as new variants of monkeypox virus emerge.

Limitations of the study included lack of randomization or blinding process, as these are lab-based studies. Secondly, this review does not evaluate the diagnostic accuracy of PCR for different clades of monkeypox virus separately due to the limited number of studies that give sufficient information on the different clades tested. Only two of the included studies elaborated on the diagnostic performance of PCR on different clades of monkeypox virus (1313. Sklenovská N, Bloemen M, Vergote V, Logist AS, Vanmechelen B, Laenen L, et al. Design and validation of a laboratory-developed diagnostic assay for monkeypox virus. Virus Genes. 2023;59(6):795–800. https://doi.org/10.1007/s11262-023-02024-9.
https://doi.org/10.1007/s11262-023-02024...
, 1515. Pond MJ, Al-Mufti J, Madona P, Crone MA, Laing KG, Hale RS, et al. Mpox infection investigation using multiplexed syndromic diagnostics: Evaluation of an AusDiagnostics multiplexed tandem PCR (MT-PCR) syndromic panel. J Clin Virol Plus. 2023;3(2):100142. https://doi.org/10.1016/j.jcvp.2023.100142.
https://doi.org/10.1016/j.jcvp.2023.1001...
). Future research must focus on large-scale prospective studies evaluating the diagnostic accuracy of PCR in diverse real-world clinical environments. Studies must also evaluate the diagnostic accuracy of PCR in detecting multiple clades of the virus. Standardization of PCR protocols across laboratories is necessary to reduce the variability and ensure consistent findings in different study settings. In spite of PCR being highly sensitive and specific in detecting mpox, it requires sophisticated laboratory settings, tools, and trained personnel, which might not be feasible in low resource settings where an mpox outbreak has occurred and the availability of PCR is limited. Therefore, alternative diagnostic tools must still be explored to complement PCR in these settings.

Conclusion

This systematic review confirms PCR as an accurate tool in detecting mpox infections in humans, with a high sensitivity and specificity across varied study settings. PCR demonstrated excellent diagnostic accuracy, making it indispensable for clinical and public health responses during outbreaks. However, lack of data on clade-specific performance highlights the need for further research to ensure robustness of PCR test across all variants of monkeypox virus.

Disclaimer.

Authors hold sole responsibility for the views expressed in the manuscript, which may not necessarily reflect the opinion or policy of the RPSP/PAJPH and/or the Pan American Health Organization (PAHO).

REFERENCES

  • 1.
    World Health Organization. WHO Director-General declares mpox outbreak a public health emergency of international concern. 14 August 2024. Geneva: WHO; 2024 [cited 17 September 2024]. Available from: https://www.who.int/news/item/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern
    » https://www.who.int/news/item/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern
  • 2.
    Jeyaraman M, Selvaraj P, Halesh MB, Jeyaraman N, Nallakumarasamy A, Gupta M, et al. Monkeypox: An Emerging Global Public Health Emergency. Life (Basel). 2022;12(10):1590. https://doi.org/10.3390/life12101590
    » https://doi.org/10.3390/life12101590
  • 3.
    Peris MP, Clusa L, Alonso H, Escolar C, Fortuño B, Rezusta A, et al. Clinical Performance Evaluation of a Rapid Real-Time PCR Assay for Monkeypox Diagnosis: a Retrospective and Comparative Study. Microbiol Spectr. 2023;11(3):e0051023. https://doi.org/10.1128/spectrum.00510-23
    » https://doi.org/10.1128/spectrum.00510-23
  • 4.
    Americo JL, Earl PL, Moss B. Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. Proc Natl Acad Sci USA. 2023;120(8):e2220415120. https://doi.org/10.1073/pnas.2220415120
    » https://doi.org/10.1073/pnas.2220415120
  • 5.
    Chaix E, Boni M, Guillier L, Bertagnoli S, Mailles A, Collignon C, et al. Risk of Monkeypox virus (MPXV) transmission through the handling and consumption of food. Microb Risk Anal. 2022;22:100237. https://doi.org/10.1016/j.mran.2022.100237
    » https://doi.org/10.1016/j.mran.2022.100237
  • 6.
    World Health Organization. Mpox. Geneva: WHO; 2024 [cited 17 September 2024]. Available from: https://www.who.int/health-topics/mpox
    » https://www.who.int/health-topics/mpox
  • 7.
    Philpott D, Hughes CM, Alroy KA, Kerins JL, Pavlick J, Asbel L, et al. Epidemiologic and clinical characteristics of monkeypox cases – United States, May 17–July 22, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(32):1018–1022. https://doi.org/10.15585/mmwr.mm7132e3
    » https://doi.org/10.15585/mmwr.mm7132e3
  • 8.
    World Health Organization. Laboratory testing for the monkeypox virus: interim guidance, 23 May 2022. Geneva: WHO; 2022. Available from: https://iris.who.int/handle/10665/354488
    » https://iris.who.int/handle/10665/354488
  • 9.
    Harshani HBC, Liyanage GA, Ruwan DVRG, Samaraweera UKIU, Abeynayake JI. Evaluation of the diagnostic performance of a commercial molecular assay for the screening of suspected monkeypox cases in Sri Lanka. Infect Med (Beijing). 2023;2(2):136–142. https://doi.org/10.1016/j.imj.2023.05.002
    » https://doi.org/10.1016/j.imj.2023.05.002
  • 10.
    McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014;58(2):260–267. https://doi.org/10.1093/cid/cit703
    » https://doi.org/10.1093/cid/cit703
  • 11.
    Cheema AY, Ogedegbe OJ, Munir M, Alugba G, Ojo TK. Monkeypox: A Review of Clinical Features, Diagnosis, and Treatment. Cureus. 2022;14(7):e26756. https://doi.org/10.7759/cureus.26756
    » https://doi.org/10.7759/cureus.26756
  • 12.
    Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis. 2004;4(6):337–348. https://doi.org/10.1016/s1473-3099(04)01044-8
    » https://doi.org/10.1016/s1473-3099(04)01044-8
  • 13.
    Sklenovská N, Bloemen M, Vergote V, Logist AS, Vanmechelen B, Laenen L, et al. Design and validation of a laboratory-developed diagnostic assay for monkeypox virus. Virus Genes. 2023;59(6):795–800. https://doi.org/10.1007/s11262-023-02024-9
    » https://doi.org/10.1007/s11262-023-02024-9
  • 14.
    Velu PD, Sipley J, Marino J, Ghanshani S, Lukose G, Cong L, et al. Evaluation of a zoonotic orthopoxvirus PCR assay for the detection of mpox virus infection. J Mol Diagn. 2023;25(10):740–747. https://doi.org/10.1016/j.jmoldx.2023.06.010
    » https://doi.org/10.1016/j.jmoldx.2023.06.010
  • 15.
    Pond MJ, Al-Mufti J, Madona P, Crone MA, Laing KG, Hale RS, et al. Mpox infection investigation using multiplexed syndromic diagnostics: Evaluation of an AusDiagnostics multiplexed tandem PCR (MT-PCR) syndromic panel. J Clin Virol Plus. 2023;3(2):100142. https://doi.org/10.1016/j.jcvp.2023.100142
    » https://doi.org/10.1016/j.jcvp.2023.100142
  • 16.
    Mostafa HH, Wall G, Su S-C, Hysa G, Gong L, Dadjeu UC, et al. Multi-center evaluation of the Research Use Only NeuMoDx monkeypox virus (MPXV) fully automated real-time PCR assay. J Clin Microbiol. 2024;62(5):e0002824. https://doi.org/10.1128/jcm.00028-24
    » https://doi.org/10.1128/jcm.00028-24
  • 17.
    Bunse T, Ziel A, Hagen P, Rigopoulos G, Yasar U, Inan H, et al. Analytical and clinical evaluation of a novel real-time PCR-based detection kit for Mpox virus. Med Microbiol Immunol. 2024;213(1):18. https://doi.org/10.1007/s00430-024-00800-4
    » https://doi.org/10.1007/s00430-024-00800-4
  • 18.
    Tan NK, Madona CP, Taylor JF, Fourali LH, Sehmi JK, Stone MJ, et al. Performance evaluation of the Viasure PCR assay for the diagnosis of monkeypox: A multicentre study. J Clin Virol. 2023;158:105350. https://doi.org/10.1016/j.jcv.2022.105350
    » https://doi.org/10.1016/j.jcv.2022.105350
  • 19.
    Pomari E, Mori A, Accordini S, Donini A, Cordioli M, Tacconelli E, et al. Evaluation of a ddPCR commercial assay for the absolute quantification of the Monkeypox virus West Africa in clinical samples. Diagnostics (Basel). 2023;13(7):1349. https://doi.org/10.3390/diagnostics13071349
    » https://doi.org/10.3390/diagnostics13071349
  • 20.
    Elbaz M, Halutz O, Ali Y, Adler A. Diagnosis of Monkeypox infection: Validation of two diagnostic kits for viral detection using RT-PCR. J Virol Methods. 2023;312:114653. https://doi.org/10.1016/j.jviromet.2022.114653
    » https://doi.org/10.1016/j.jviromet.2022.114653
  • 21.
    De Pace V, Bruzzone B, Ricucci V, Domnich A, Guarona G, Garzillo G, et al. Molecular Diagnosis of Human Monkeypox Virus during 2022–23 Outbreak: Preliminary Evaluation of Novel Real-Time Qualitative PCR Assays. Microorganisms. 2024;12(4):664. https://doi.org/10.3390/microorganisms12040664
    » https://doi.org/10.3390/microorganisms12040664
  • 22.
    Wettengel JM, Bunse T, Jeske SD, Wölfel R, Zange S, Taeubner J, et al. Implementation and clinical evaluation of an Mpox virus laboratory-developed test on a fully automated random-access platform. J Med Virol. 2023;95(8):e29022. https://doi.org/10.1002/jmv.29022
    » https://doi.org/10.1002/jmv.29022
  • 23.
    Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536. https://doi.org/10.7326/0003-4819-155-8-201110180-00009
    » https://doi.org/10.7326/0003-4819-155-8-201110180-00009
  • 24.
    Nyaga VN. METADTA: Stata module to perform fixed- and random-effects meta-analysis and meta-regression of diagnostic accuracy studies. Statistical Software Components S458794. Boston College Department of Economics; 2020. Revised 11 November 2022. Available from: https://ideas.repec.org/c/boc/bocode/s458794.html
    » https://ideas.repec.org/c/boc/bocode/s458794.html
  • 25.
    Nyaga VN, Arbyn M. Metadta: a Stata command for meta-analysis and meta-regression of diagnostic test accuracy data - a tutorial. Arch Public Health. 2022;80(1):95. https://doi.org/10.1186/s13690-021-00747-5
    » https://doi.org/10.1186/s13690-021-00747-5

Publication Dates

  • Publication in this collection
    10 Jan 2025
  • Date of issue
    2024

History

  • Received
    26 Sept 2024
  • Accepted
    11 Oct 2024
Organización Panamericana de la Salud Washington - Washington - United States
E-mail: contacto_rpsp@paho.org